An analy­sis of the first two months of claims data from the fed­er­al and state mar­ket­places show that new enrollees are more like­ly to use expen­sive spe­cial­ty drugs to treat con­di­tions such as HIV/AIDS and hepati­tis C than those with job based insur­ance. It’s only two months, but…and the experts are naysay­ers and sup­port­ers agree with them and so on…but it should be watched